New Treatment Concept

In 2016, nearly 600,000 Americans died of cancer. Cancer is the second most common cause of death in the US after heart disease. Compared to the economic impact of premature…+Learn More

DfuseRxSM

We are pioneering a new approach to treat solid tumor cancers. Our Company’s treatment addresses both the regional and systemic aspects of cancer. The Company’s DfuseRxSM platform technology can rapidly…+Learn More

In Vivo Results

Our products show potent anticancer effectiveness in challenging mouse tumor types.  Animals having a complete response become immunized against the cancer. Using mouse models of severe, late-stage pancreatic, breast, melanoma and…+Learn More

Back to Top